
Platelet Rich Plasma Market, By Type (Pure PRP, Leukocyte rich PRP, Pure PRF, Leukocyte rich PRF), By Origin (Autologous, Allogenic, Homologues), By Application (Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, Others), and By Region (
Description
Platelet Rich Plasma Market, By Type (Pure PRP, Leukocyte rich PRP, Pure PRF, Leukocyte rich PRF), By Origin (Autologous, Allogenic, Homologues), By Application (Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its wide application and no side effects. Platelet rich plasma is used for the treatment of injured tendons, muscle, joints, and ligaments. Use of PRP therapy on patients with low back pain helps them to recover. It is also widely used for the treatment for baldness, as PRP treatment increase the blood flow. In turn supporting the hair growth.
Restraints of the Global Platelet Rich Plasma Market
Major factors hampering the growth of the platelet rich plasma market during the forecast period constitutes of uncertainty about therapeutic efficacy of platelet-rich plasma.
Key features of the study:
This report provides in-depth analysis of the global platelet rich plasma market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global platelet rich plasma market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Platelet Rich Plasma Market, By Type:
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
Global Platelet Rich Plasma Market, By Origin:
Autologous
Allogenic
Homologues
Global Platelet Rich Plasma Market, By Application:
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
Global Platelet Rich Plasma Market, By Geography:
North America
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
U.S.
Canada
Europe
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Arthrex, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Stryker Corporation
Johnson and Johnsons Ltd.
Zimmer Biomet Holdings Inc.
Terumo Corporation
Glofinn Oy
Medira Ltd.
Regen Lab S.A.
CollPlant
Generex Biotechnology Corporation
Estar Technologies Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Platelet rich plasma (PRP) is a portion of the plasma fraction of analogous blood, which contains platelet concentration more than standard concentration. Platelets contains bio proteins that helps in healing, tissue regeneration, and blood loss. Platelet rich plasma protein consists of three proteins, which acts as cell adhesive molecules that are fibrin, fibronectin, and vitronectin. The use of platelet rich plasma therapy is tremendously increased after 2009 due to its wide application and no side effects. Platelet rich plasma is used for the treatment of injured tendons, muscle, joints, and ligaments. Use of PRP therapy on patients with low back pain helps them to recover. It is also widely used for the treatment for baldness, as PRP treatment increase the blood flow. In turn supporting the hair growth.
Restraints of the Global Platelet Rich Plasma Market
Major factors hampering the growth of the platelet rich plasma market during the forecast period constitutes of uncertainty about therapeutic efficacy of platelet-rich plasma.
Key features of the study:
This report provides in-depth analysis of the global platelet rich plasma market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global platelet rich plasma market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, and Estar Technologies Ltd
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global platelet rich plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Platelet Rich Plasma Market, By Type:
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
Global Platelet Rich Plasma Market, By Origin:
Autologous
Allogenic
Homologues
Global Platelet Rich Plasma Market, By Application:
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
Global Platelet Rich Plasma Market, By Geography:
North America
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
U.S.
Canada
Europe
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type
Pure PRP
Leukocyte rich PRP
Pure PRF
Leukocyte rich PRF
By Origin
Autologous
Allogenic
Homologues
By Application
Neurosurgery
Cosmetic Surgery
Orthopedic Surgery
General Surgery
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Arthrex, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Stryker Corporation
Johnson and Johnsons Ltd.
Zimmer Biomet Holdings Inc.
Terumo Corporation
Glofinn Oy
Medira Ltd.
Regen Lab S.A.
CollPlant
Generex Biotechnology Corporation
Estar Technologies Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
184 Pages
- 1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Origin
- Market Snippet, By Application
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- 4. Global Platelet Rich Plasma Market, By Type, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Pure PRP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Leukocyte rich PRP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Pure PRF
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- Leukocyte rich PRF
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Segment Trends
- 5. Global Platelet Rich Plasma Market, By Origin, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Allogenic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Homologues
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 6. Global Platelet Rich Plasma Market, By Application, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Neurosurgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Cosmetic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Orthopedic Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- General Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 7. Global Platelet Rich Plasma Market, By Regions, 2017 - 2028 (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- 8. Competitive Landscape
- Company Profiles
- Arthrex, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnsons Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zimmer Biomet Holdings Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glofinn Oy
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medira Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regen Lab S.A
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies.
- CollPlant
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Generex Biotechnology Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Estar Technologies Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 9. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 32 market data tables and 24 figures on “Platelet Rich Plasma Market – Global forecast to 2028.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.